Clinical Trials Logo

Clinical Trial Summary

- Indication: Protection against varicella and herpes zoster

- Study Objectives

- Primary: Safety and tolerability assessment after single dose administration of NBP608

- Secondary: immunogenicity assessment after single dose administration of NBP608


Clinical Trial Description

This is a single-center, open label, active controlled, dose-escalation, parallel group study to assess the safety, tolerability and immunogenicity of NBP608 in healthy adult volunteers. Total of 150 healthy subjects aged 20 and over are enrolled, and each subject is administered with single dose of vaccine which is sequentially assigned to active group 1, 2 and study group 1~3 in 1:1:1:1:1 ratio(30 subjects are enrolled at each groups) . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03121638
Study type Interventional
Source SK Chemicals Co.,Ltd.
Contact
Status Completed
Phase Phase 1
Start date November 2012
Completion date March 2013

See also
  Status Clinical Trial Phase
Recruiting NCT03854630 - Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection Phase 4
Completed NCT04042246 - Effect of Knowledge on Vaccine Take-up in Adamawa State, Northeastern Nigeria N/A
Enrolling by invitation NCT05570630 - VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination N/A
Completed NCT03145324 - Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations
Recruiting NCT06185647 - Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis
Recruiting NCT05215327 - High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients Phase 2
Completed NCT03355989 - Evaluation of Conditional Cash Transfers (CCTs) for Immunization N/A
Completed NCT02992925 - Phase 3 Study of BK1310 in Healthy Infants Phase 3
Not yet recruiting NCT05171946 - Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults Phase 1
Completed NCT05661890 - Seasonal Influenza and Pneumococcal Vaccination in the Elderly
Active, not recruiting NCT04444518 - Increasing Influenza and Tdap Vaccination of Pregnant Women N/A
Active, not recruiting NCT03908164 - Optimising the Timing of Whooping Cough Immunisation in MUMs Phase 4
Completed NCT03379467 - Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage N/A
Not yet recruiting NCT03402646 - Mobile Phone Reminders (and Photovoice) for Routine Immunization in Nigeria - The MOPING Study N/A
Completed NCT04824638 - BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers Phase 2
Recruiting NCT05774093 - Evaluation of COVID-19 Immune Barrier and Reinfection Risk
Completed NCT03083158 - Immunity to Hepatitis B Vaccine Phase 4
Recruiting NCT04816760 - Immune Cells Phenotypes During COVID-19
Completed NCT04870021 - Hepatitis B Birth Dose for Newborns Phase 4
Completed NCT03519373 - Pertussis Immunization During Pregnancy & HIV Infection